Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0279
Source ID: NCT00452478
Associated Drug: Lanthanum Carbonate
Title: Conversion From Standard Phosphate Binder Therapy to FosrenolĀ® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Kidney Diseases
Interventions: DRUG: Lanthanum carbonate
Outcome Measures: Primary: Percentage of subjects achieving serum phosphorus levels of less than or equal to 1.78 mmol/L (5.5 mg/dL) following treatment with Fosrenol at Week 12 compared to treatment with their previous phosphate binder therapy, 12 weeks | Secondary: The maintenance of mean serum phosphorus levels following treatment with 2250 mg/day of Fosrenol, at Week 2 compared to baseline|Biochemical and haematological parameters, measured throughout the study|Assess safety & tolerability, Throughout the study
Sponsor/Collaborators: Sponsor: Shire
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 68
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2007-05-22
Completion Date: 2007-12-10
Results First Posted:
Last Update Posted: 2021-05-25
Locations: Landeskrankenhaus Feldkirch, Abteilung fur Nephrologie und dialyse, Feldkirch Tisis, A-6807, Austria|Krankenhaus Elisabethinen/Dialysestation, Linz, A-4010, Austria|Ziekenhuis Zuid Oost Limburg, Genk, 3600, Belgium|Frederica Sygehus, Fredericia, 7000, Denmark|Holbaek Sykehus, Holbaek, DK-4300, Denmark|Sygehus Viborg, Viborg, 88 00, Denmark|Dialysezentrum Barmbek, Hamburg, 22297, Germany|Dialysezentrum Heilbronn, Heilbronn, 74076, Germany|Dialyse Leipzig, Leipzig, 04178, Germany|Nephrologisches Zentrum Emsland, Lingen, 49808, Germany|nephrologische Schwerpunktpraxis, Oldenburg, 26127, Germany|diabetologische Schwerpunktpraxis, Villingen-Schwenningen, 78054, Germany|University of Milan, San Paolo Hospital, Renal Division, Milan, Italy|Gelre Ziekenhuizen, Apeldoorn, 7334 DZ, Netherlands
URL: https://clinicaltrials.gov/show/NCT00452478